Significance of Co-mutations in BCR-ABL1 Negative Myeloproliferative Neoplasms

被引：0
|
作者：
Zhou, Yi [1 ]
机构：
[1] Univ Miami, Miami, FL USA
来源：
LABORATORY INVESTIGATION | 2022年 / 102卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
973
引用
收藏
页码：1054 / 1054
页数：1
相关论文
共 50 条
  • [1] Significance of Co-mutations in BCR-ABL1 Negative Myeloproliferative Neoplasms
    Zhou, Yi
    MODERN PATHOLOGY, 2022, 35 (SUPPL 2) : 1054 - 1054
  • [2] Molecular genetics of BCR-ABL1 negative myeloproliferative neoplasms in India
    Rabade, Nikhil
    Subramanian, P. G.
    Kodgule, Rohan
    Raval, Goutham
    Joshi, Swapnali
    Chaudhary, Shruti
    Mascarenhas, Russel
    Tembhare, Prashant
    Gujral, Sumeet
    Patkar, Nikhil
    INDIAN JOURNAL OF PATHOLOGY AND MICROBIOLOGY, 2018, 61 (02) : 209 - 213
  • [3] Myeloproliferative neoplasms (BCR-ABL1 negative) and myelodysplastic/myeloproliferative neoplasms: current diagnosticprinciples and upcoming updates
    Geyer, J. T.
    Orazi, A.
    INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY, 2016, 38 : 12 - 19
  • [4] Immunophenotypic Aberrancy on Basophils, a Biomarker for BCR-ABL1 Negative Myeloproliferative Neoplasms
    Chu, Andrew
    Kumar, Kirthi
    Monaghan, Sara A.
    Fuda, Franklin
    Chen, Weina
    LABORATORY INVESTIGATION, 2016, 96 : 340A - 340A
  • [5] Oxidant/Antioxidant Status in Patients with BCR-ABL1 Negative Myeloproliferative Neoplasms
    Benguella-Benmansour, Meriem
    Boucherit, Kebir
    Mesli, Naima
    INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, 2025, 41 (01) : 23 - 30
  • [6] Immunophenotypic Aberrancy on Basophils, a Biomarker for BCR-ABL1 Negative Myeloproliferative Neoplasms
    Chu, Andrew
    Kumar, Kirthi
    Monaghan, Sara A.
    Fuda, Franklin
    Chen, Weina
    MODERN PATHOLOGY, 2016, 29 : 340A - 340A
  • [7] Risk-adapted treatment of chronic BCR-ABL1 negative myeloproliferative neoplasms
    Heidel, Florian H.
    Doehner, Konstanze
    ONKOLOGE, 2019, 25 (11): : 985 - 993
  • [8] Risk factors of thrombosis in a cohort of 206 patients with BCR-ABL1 negative myeloproliferative neoplasms
    Aswad, Mohamed Hussam
    Kissova, Jarmila
    Ovesna, Petra
    Penka, Miroslav
    NEOPLASMA, 2021, 68 (06) : 1341 - 1350
  • [9] Diagnostic and therapeutic pitfalls of the BCR-ABL1 negative myeloproliferative neoplasms (MPNs) associated thromboembolism
    Schilling, K.
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 : 132 - 132
  • [10] BCR-ABL negative myeloproliferative neoplasms
    Metzgeroth, G.
    Lengfelder, E.
    Griesshammer, M.
    Reiter, A.
    ONKOLOGE, 2012, 18 (12): : 1130 - +
12345